New insulin pump study aims to improve blood sugar control in type 2 diabetes
NCT ID NCT07068295
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This study tested a new fast-acting insulin (NNC0471-0119) given through an insulin pump in 65 people with type 2 diabetes. The goal was to see how quickly it works, how long it lasts, and how safe it is compared to a standard insulin (insulin aspart). Participants were adults aged 18-69 who already used insulin. The study lasted up to 2 months and measured blood sugar lowering effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.